Sales decline 26.21% to Rs 426.79 crore
Net loss of Nectar Lifescience reported to Rs 7.31 crore in the quarter ended September 2020 as against net profit of Rs 2.45 crore during the previous quarter ended September 2019. Sales declined 26.21% to Rs 426.79 crore in the quarter ended September 2020 as against Rs 578.35 crore during the previous quarter ended September 2019. ParticularsQuarter EndedSep. 2020Sep. 2019% Var.Sales426.79578.35 -26 OPM %7.378.27 -PBDT4.1216.36 -75 PBT-10.982.59 PL NP-7.312.45 PLPowered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
